1 min read
Add as a preferred source on Google

Greenwich LifeSciences Shares Gain More Than 25% After Trial Poster News

Two posters at an upcoming medical event will cover FLAMINGO-01, the company’s Phase 3 cancer trial.

Two blank research posters hang in an empty convention hall / TokenPost.ai
Two blank research posters hang in an empty convention hall / TokenPost.ai

Greenwich LifeSciences, Inc. shares rose more than 25% Tuesday, Nov. 17, after the company disclosed that two posters about its FLAMINGO-01 Phase 3 cancer trial are scheduled for an upcoming medical event.

The company trades on Nasdaq as GLSI.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…